The executive director of the Medicines Patent Pool (MPP) says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
MPP, LSPN Connect, Medicines Patent Pool, voluntary licensing, COVID-19, pandemic, Charles Gore, Big Pharma, drug companies, HIV, hepatitis C, WHO, UN